Botulinum Toxin Market Growth, Size and Share Analysis by Type (Botulinum Toxin A and Botulinum Toxin B), Application (Aesthetic and Therapeutic), End User (Dermatology Centers, Hospitals and Clinics) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2025
Botulinum Toxin Market Scope of the Report
Market Research Future (MRFR) expects the botulinum toxin market size to maintain a steady growth pattern and advance at a rate of 10.3% from 2018 to 2025 (evaluation period). The botulinum toxin market share value by 2025 can be USD 9442.93 Million, adds MRFR. We will provide COVID-19 impact analysis with the report, offering an in-depth review following the coronavirus disease outbreak.
Botulinum toxin or BNT finds extensive use in aesthetic purposes. However, at present, its commercial availability in the botulinum toxin market is quite low, which has some impact on its demand worldwide. But sizeable investments in R&D activities to come up with BNT’s therapeutic use are creating excellent opportunities in terms of expanding application scope. Burgeoning population that is aged from 25 to 65 years coupled with the soaring demand for non-invasive or minimally invasive procedures can further enhance the botulinum toxin market size.
Request Free Sample Copy of the report “Global Botulinum Toxin Market Research Report—Forecast till 2025” at: https://www.marketresearchfuture.com/sample_request/8567
The sharp spike in cases of cervical dystonia, chronic migraine and spasticity across the world along with the rising preference for facial aesthetics has been favorable for the BNT market. The increased number of product launches and the surge in FDA approvals are also likely to benefit the botulinum toxin industry in the forthcoming years.
To illustrate, in September 2020, Ipsen Biopharmaceuticals was able to get FDA approval for its Dysport/abobotulinumtoxinA targeted at pediatric patients. This approval will now allow the company to cater to children affected by cerebral palsy and offer them access to spasticity treatment involving the use of Dysport.
One of the major trends in recent times has been the rising focus on facial aesthetics and physical appearance, which has bolstered the demand for botulinum toxin worldwide. But the ill effects of botulinum toxin along with the unfavorable reimbursement scenario across a few countries can deter the market growth in the following years. The upside can be the increasing number of successfully completed research projects that strive to boost the application scope of BTN and their rising introduction into the botulinum toxin market.
Botulinum Toxin Market Segmentation
The botulinum toxin market analysis by MRFR highlights a few key segments, namely type, application and end-user.
The main types of Botulinum Toxin in the market are botulinum toxin type A and B. Botulinum toxin type A can most likely secure the leading position with a share of 96.29% over the forecast period, given the high availability of these types across the globe. Dysport (Galderma SA), Xeomin (Merz Pharma GmbH & Co KGaA) and Botox (Allergan PLC) are the most significant brands that sell botulinum toxin A types in the worldwide botulinum toxin market.
Applications mentioned in the botulinum toxin market report are therapeutic as well as aesthetic applications. The therapeutic-based segments specified in the study are blepharospasm, chronic migraine, overactive bladder, cervical dystonia, spasticity, and more.
Some of the top end users in the global botulinum toxin market are Hospitals & Clinics, dermatology Centers, and more.
Botulinum Toxin Market Regional Outlook
Botulinum toxin market share is split into primary regions of Europe, Asia Pacific or APAC, MEA or Middle East & Africa and the Americas.
The Americas, with the presence of highly developed countries like Canada and the United States, can most likely take the lead botulinum toxin market over the next few years, thanks to the surging spasticity cases. The extensive spread of renowned manufacturers like Evolus Inc., US WorldMeds, LLC, Revance Therapeutics Inc. and Hugel, Inc. in the region and the increase in product approvals by FDA also benefits the American market. For instance, in September 2020, AEON Biopharma Inc. received approval by FDA for its IND/Investigational New Drug use in ABP-450 for the treatment of cervical dystonia. The approval has helped the company boost its therapeutic botulinum toxin portfolio to a large extent.
The European botulinum toxin market is primarily made of Western Europe and Eastern Europe. Western Europe consists of developed nations like Germany, France, the UK, Spain and Italy, where demand for facial aesthetics is quite significant and therefore, the number of botulinum toxin procedures has risen in recent years. High social media presence in the
region and its effect on the youth with regard to physical appearance and grooming also leads the BTN market in the region to greater heights.
The APAC botulinum toxin market is on track to procure the fastest growth rate of 11.01% between 2019 and 2025, as a result of the presence of the target demographics and the surge in disposable income of people in the region. The fast expanding older population and the growing preference for anti-aging products also add to the market strength. The region is continuously observing a surge in social awareness with regard to the accessibility of BTN products in the botulinum toxin market, which has translated considerable business growth.
Botulinum Toxin Market Key Players
Some of the most reputed companies in the global botulinum toxin market are US WorldMeds LLC. (Solstice Neurosciences, LLC), Galderma S.A., Merz Pharma GmbH & Co KGaA, Allergan PLC, Hugel, Inc, Medytox, Revance Therapeutics Inc, Ipsen Pharma, Daewoong Pharmaceutical Co., Ltd, Evolus Inc., to mention a few.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/botulinum-toxin-market-8567
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
